ReviewCells2019

Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives.

Louise Coppin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.